How to buy Summit Therapeutics stock
Learn how to easily invest in Summit Therapeutics stock.
Summit Therapeutics is a biotechnology business based in the US. Summit Therapeutics shares (SMMT) are listed on the NASDAQ and all prices are listed in US Dollars. Summit Therapeutics employs 76 staff and has a trailing 12-month revenue of around $220,000.
How to buy Summit Therapeutics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SMMT. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Summit Therapeutics stock price (NASDAQ: SMMT)Use our graph to track the performance of SMMT stocks over time.
Summit Therapeutics shares at a glance
|Latest market close||$1.87|
|52-week range||$0.66 - $5.78|
|50-day moving average||$1.86|
|200-day moving average||$2.30|
|Wall St. target price||$5.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.18|
Buy Summit Therapeutics stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Summit Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Summit Therapeutics price performance over time
|1 week (2023-09-20)||0.54%|
|1 month (2023-08-25)||5.06%|
|3 months (2023-06-27)||-26.38%|
|6 months (2023-03-27)||8.72%|
|1 year (2022-09-27)||54.55%|
|2 years (2021-09-24)||-64.18%|
|3 years (2020-09-25)||3.42|
|5 years (2018-09-27)||2.23|
Summit Therapeutics financials
|Gross profit TTM||$705,000|
|Return on assets TTM||-23.29%|
|Return on equity TTM||-699.42%|
|Market Capitalization||$1.3 billion|
TTM: trailing 12 months
Summit Therapeutics share dividends
We're not expecting Summit Therapeutics to pay a dividend over the next 12 months.
Have Summit Therapeutics's shares ever split?
Summit Therapeutics's shares were split on 20 September 2020.
Summit Therapeutics share price volatility
Over the last 12 months, Summit Therapeutics's shares have ranged in value from as little as $0.66 up to $5.78. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Summit Therapeutics's is -0.8389. This would suggest that Summit Therapeutics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Summit Therapeutics has bucked the trend.
Summit Therapeutics overview
Summit Therapeutics Inc. , a biopharmaceutical company, research and develops primarily oncology therapies in the United States, and the United Kingdom. The company's product pipeline includes SMT-738, a novel class of precision antibiotics for treatment which is in preclinical stage for the treatment of multidrug resistant infections, which primarily includes carbapenem-resistant Enterobacteriaceae infections. It has a collaboration and license agreement with Akeso, Inc. for research and develop Ivonescimab (AK112) and SMT112, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis. The company was founded in 2003 and is headquartered in Cambridge, Massachusetts. .
Frequently asked questionsWhat percentage of Summit Therapeutics is owned by insiders or institutions?
Currently 29.614% of Summit Therapeutics shares are held by insiders and 3.268% by institutions. How many people work for Summit Therapeutics?
Latest data suggests 76 work at Summit Therapeutics. When does the fiscal year end for Summit Therapeutics?
Summit Therapeutics's fiscal year ends in January. Where is Summit Therapeutics based?
Summit Therapeutics's address is: One Broadway, Cambridge, MA, United States, 02142 What is Summit Therapeutics's ISIN number?
Summit Therapeutics's international securities identification number is: US86627T1088 What is Summit Therapeutics's CUSIP number?
Summit Therapeutics's Committee on Uniform Securities Identification Procedures number is: 86627R102
More guides on Finder
How to buy Discord stock when it goes public
Everything we know about the Discord IPO, plus information on how to buy in.
Today’s trending Reddit stocks
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
How to buy Tottenham Acquisition I stock
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
How to buy TotalEnergies stock
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
How to buy Thunder Bridge Acquisition stock
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
How to buy Switchback Energy Acquisition Corporation stock
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
How to buy Telefonica SA ADR stock
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
How to buy Faraday Future stock
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
How to buy Phoenix Tree stock
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
How to buy Innate Pharma stock
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.
Ask an Expert